These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 7744216)

  • 21. [Mechanisms of action of peroral antidiabetics. Sulfonylurea preparations block the ATP-dependent potassium channels].
    Larsson O; Kindmark H; Bränström R; Berggren PO
    Lakartidningen; 1997 Nov; 94(48):4473-7. PubMed ID: 9424548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular biology of adenosine triphosphate-sensitive potassium channels.
    Aguilar-Bryan L; Bryan J
    Endocr Rev; 1999 Apr; 20(2):101-35. PubMed ID: 10204114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of repaglinide on cloned beta cell, cardiac and smooth muscle types of ATP-sensitive potassium channels.
    Dabrowski M; Wahl P; Holmes WE; Ashcroft FM
    Diabetologia; 2001 Jun; 44(6):747-56. PubMed ID: 11440368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissociation of KATP channel and sulphonylurea receptor in the rat clonal insulin-secreting cell line, CRI-D11.
    Khan RN; Hales CN; Ozanne SE; Adogu AA; Ashford ML
    Proc Biol Sci; 1993 Sep; 253(1338):225-31. PubMed ID: 7694299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs.
    Yao Z; Gross GJ
    Circulation; 1994 Apr; 89(4):1769-75. PubMed ID: 8149542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blockade of vascular ATP-sensitive potassium channels reduces the vasodilator response to ischaemia in humans.
    Bijlstra PJ; den Arend JA; Lutterman JA; Russel FG; Thien T; Smits P
    Diabetologia; 1996 Dec; 39(12):1562-8. PubMed ID: 8960843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-ischaemic actions of potassium channel openers in experimental myocardial ischaemia/reperfusion injury in dogs.
    Auchampach JA; Gross GJ
    Eur Heart J; 1993 Jul; 14 Suppl B():10-5. PubMed ID: 8370365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired glucose sensitivity of ATP-sensitive K+ channels in pancreatic beta-cells in streptozotocin-induced NIDDM rats.
    Tsuura Y; Ishida H; Okamoto Y; Tsuji K; Kurose T; Horie M; Imura H; Okada Y; Seino Y
    Diabetes; 1992 Jul; 41(7):861-5. PubMed ID: 1612201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What kind of cardiovascular alterations could be influenced positively by oral antidiabetic agents?
    Pogátsa G
    Diabetes Res Clin Pract; 1996 Jul; 31 Suppl():S27-31. PubMed ID: 8864638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
    Nielsen-Kudsk JE
    Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ATP gated potassium channels in acute myocardial hibernation and reperfusion.
    Offstad J; Kirkebøen KA; Ilebekk A; Downing SE
    Cardiovasc Res; 1994 Jun; 28(6):872-80. PubMed ID: 7923294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blockade of adenosine triphosphate-sensitive potassium channels by thiamylal in rat ventricular myocytes.
    Tsutsumi Y; Oshita S; Kitahata H; Kuroda Y; Kawano T; Nakaya Y
    Anesthesiology; 2000 Apr; 92(4):1154-9. PubMed ID: 10754636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The high-affinity sulphonylurea receptor regulates KATP channels in nerve terminals of the rat motor cortex.
    Lee K; Dixon AK; Rowe IC; Ashford ML; Richardson PJ
    J Neurochem; 1996 Jun; 66(6):2562-71. PubMed ID: 8632183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of ATP-sensitive K+ channels in cardiac muscle by the sulphonylurea drug glibenclamide.
    Findlay I
    J Pharmacol Exp Ther; 1992 May; 261(2):540-5. PubMed ID: 1578371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gliclazide produces high-affinity block of KATP channels in mouse isolated pancreatic beta cells but not rat heart or arterial smooth muscle cells.
    Lawrence CL; Proks P; Rodrigo GC; Jones P; Hayabuchi Y; Standen NB; Ashcroft FM
    Diabetologia; 2001 Aug; 44(8):1019-25. PubMed ID: 11484080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sulphonylurea drugs no longer inhibit ATP-sensitive K+ channels during metabolic stress in cardiac muscle.
    Findlay I
    J Pharmacol Exp Ther; 1993 Jul; 266(1):456-67. PubMed ID: 8331572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ATP-sensitive and inwardly rectifying potassium channels in smooth muscle.
    Quayle JM; Nelson MT; Standen NB
    Physiol Rev; 1997 Oct; 77(4):1165-232. PubMed ID: 9354814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac ATP-sensitive K+ channels: regulation by intracellular nucleotides and K+ channel-opening drugs.
    Terzic A; Jahangir A; Kurachi Y
    Am J Physiol; 1995 Sep; 269(3 Pt 1):C525-45. PubMed ID: 7573382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of sulfonylurea receptor type 1 subunits of ATP-sensitive potassium channels in myocardial ischemia/reperfusion injury.
    Elrod JW; Harrell M; Flagg TP; Gundewar S; Magnuson MA; Nichols CG; Coetzee WA; Lefer DJ
    Circulation; 2008 Mar; 117(11):1405-13. PubMed ID: 18316485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effects of ATP-sensitive potassium-channel openers in experimental myocardial ischemia.
    Grover GJ
    J Cardiovasc Pharmacol; 1994; 24 Suppl 4():S18-27. PubMed ID: 7898104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.